Last updated: 7 June 2024 at 4:56pm EST

Helen Louise Collins Net Worth




The estimated Net Worth of Helen Louise Collins is at least $1.93 Milión dollars as of 11 December 2020. Helen Collins owns over 22,000 units of Kura Oncology Inc stock worth over $1,930,686 and over the last 8 years Helen sold KURA stock worth over $0.

Helen Collins KURA stock SEC Form 4 insiders trading

Helen has made over 2 trades of the Kura Oncology Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Helen exercised 22,000 units of KURA stock worth $437,360 on 11 December 2020.

The largest trade Helen's ever made was exercising 22,000 units of Kura Oncology Inc stock on 11 December 2020 worth over $437,360. On average, Helen trades about 1,630 units every 1 days since 2017. As of 11 December 2020 Helen still owns at least 97,117 units of Kura Oncology Inc stock.

You can see the complete history of Helen Collins stock trades at the bottom of the page.



What's Helen Collins's mailing address?

Helen's mailing address filed with the SEC is C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA, 92130.

Insiders trading at Kura Oncology Inc

Over the last 6 years, insiders at Kura Oncology Inc have traded over $16,903,587 worth of Kura Oncology Inc stock and bought 50,000 units worth $575,000 . The most active insiders traders include Faheem Hasnain, Troy Edward Wilson a Mary T Szela. On average, Kura Oncology Inc executives and independent directors trade stock every 63 days with the average trade being worth of $626,260. The most recent stock trade was executed by Teresa Brophy Bair on 20 May 2024, trading 2,615 units of KURA stock currently worth $57,922.



What does Kura Oncology Inc do?

at kura oncology, we are committed to realizing the promise of precision medicines for cancer. the genomics revolution is transforming how we treat cancer. we now understand that how a patient responds to treatment depends in part on the genetic makeup of the cancer and, importantly, we have the knowledge and tools to create targeted treatments and companion diagnostics to identify those patients most likely to benefit. this new era offers the potential for innovative treatments that are safer and more effective for patients with particular cancers. we are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. our development programs target cancers with high unmet need, including lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias. our goal is to help patients with cancer lead better, longer lives.



What does Kura Oncology Inc's logo look like?

Kura Oncology Inc logo

Complete history of Helen Collins stock trades at Five Prime Therapeutics Inc a Kura Oncology Inc

Dátum
#
Spoločnosť
Človek
Trans.
Transakcia
Počet akcií Cena za akciu Celková cena Počet akcií po Zdroj
11 Dec 2020 Helen Louise Collins
EVP a Chief Medical Officer
Využitie opcie 22,000 $16.14 $355,080
11 Dec 2020
97,117
11 Nov 2020 Helen Louise Collins
EVP a Chief Medical Officer
Využitie opcie 22,000 $18.00 $396,000
11 Nov 2020
86,156


Kura Oncology Inc executives and stock owners

Kura Oncology Inc executives and other stock owners filed with the SEC include: